|
|
Volumn 362, Issue 6413, 2018, Pages 394-
|
|
A scientist's fraudulent studies put patients at risk
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ETHICS;
FRAUD;
HEALTH CARE PRACTICE;
HUMAN;
MEDICAL RESEARCH;
MEDICOLEGAL ASPECT;
NOTE;
PATIENT CARE;
PATIENT SAFETY;
PRIORITY JOURNAL;
RISK;
SCIENTIFIC MISCONDUCT;
SCIENTIST;
ADMINISTRATION AND DOSAGE;
CHEMICALLY INDUCED;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY DISEASE;
SOLUTION AND SOLUBILITY;
HETASTARCH DERIVATIVE;
ADMINISTRATION, INTRAVENOUS;
BIOMEDICAL RESEARCH;
HUMANS;
HYDROXYETHYL STARCH DERIVATIVES;
KIDNEY DISEASES;
PATIENT SAFETY;
PHARMACEUTICAL SOLUTIONS;
RISK;
SCIENTIFIC MISCONDUCT;
|
|
EID: 85055612986
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.362.6413.394-a Document Type: Note |
|
Times cited : (16)
|
|
References (0)
|
